We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+55.36%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$730M
AUM Growth
+$297M
Cap. Flow
+$114M
Cap. Flow %
15.59%
Top 10 Hldgs %
75.34%
Holding
50
New
15
Increased
11
Reduced
5
Closed
10

Top Buys

1
IMMU
Immunomedics Inc
IMMU
+$28.5M
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$28M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$22M
4
ASND icon
Ascendis Pharma A/S
ASND
+$17.9M
5
KURA icon
Kura Oncology
KURA
+$16.3M

Top Sells

1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$29.5M
2
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$25.9M
3
EDIT icon
Editas Medicine
EDIT
+$12M
4
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$4.52M
5
ACHN
Achillion Pharmaceuticals
ACHN
+$3.41M

Sector Composition

1 Healthcare 90.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
26
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.34M 0.46%
222,388
-2,345,731
-91% -$25.9M
CMTA
27
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$3.28M 0.45%
+194,166
New +$3.17M
ADVM
28
DELISTED
Adverum Biotechnologies
ADVM
$2.79M 0.38%
76,295
-11,150
-13% -$309K
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
$2.12M 0.29%
25,765
+15,765
+158% +$1.25M
XNCR icon
30
Xencor
XNCR
$1.11B
$2.06M 0.28%
+90,114
New +$2M
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
$1.63M 0.22%
30,000
+15,000
+100% +$768K
ACRS icon
32
Aclaris Therapeutics
ACRS
$782M
$1.55M 0.21%
60,000
-125,472
-68% -$3.36M
SYRS
33
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.53M 0.21%
+10,400
New +$1.96M
BMY icon
34
Bristol-Myers Squibb
BMY
$120B
$1.09M 0.15%
17,060
– –
ONC
35
BeOne Medicines Ltd
ONC
$32.3B
$1.01M 0.14%
+9,800
New +$730K
DCPH
36
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$855K 0.12%
+45,000
New +$824K
FSTX
37
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$269K 0.04%
+4,000
New +$229K
AGIO icon
38
Agios Pharmaceuticals
AGIO
$2.37B
– –
-23,300
Closed -$1.2M
ALNY icon
39
Alnylam Pharmaceuticals
ALNY
$37.3B
– –
-10,425
Closed -$831K
EDIT icon
40
Editas Medicine
EDIT
$467M
– –
-717,107
Closed -$12M
GILD icon
41
Gilead Sciences
GILD
$164B
– –
0
– –
NERV icon
42
Minerva Neurosciences
NERV
$201M
– –
-27,975
Closed -$1.98M
VRTX icon
43
Vertex Pharmaceuticals
VRTX
$121B
– –
0
– –
CCXI
44
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-118,000
Closed -$1.1M
ALXN
45
DELISTED
Alexion Pharmaceuticals
ALXN
– –
0
– –
NBRV
46
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
-1,059
Closed -$2.77M
TTPH
47
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-31,670
Closed -$4.52M
ACHN
48
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-742,835
Closed -$3.41M
PETX
49
DELISTED
Aratana Therapeutics, Inc.
PETX
– –
-100,000
Closed -$723K
BHVN
50
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-70,000
Closed -$1.75M
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return